Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 532

2.

Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.

Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML, Reddy KS, Cidambi R, Bompoint S, Billot L, Rodgers A; UMPIRE Collaborative Group..

JAMA. 2013 Sep 4;310(9):918-29. doi: 10.1001/jama.2013.277064. Erratum in: JAMA. 2013 Oct 9;310(14):1507. Naik, Nitish [added]; Reddy, Srinivas [added]; Balaji, Sham [corrected to Achuthan, Shyambalaji]; Damodra Rao, Modem [corrected to Damodra Rao, Kodem].

PMID:
24002278
3.

Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.

Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T.

J Manag Care Pharm. 2012 Sep;18(7):516-26.

4.

Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.

Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, Singh RF, Wood Y, Kaplan RM, Mangione CM.

Clin Ther. 2014 Sep 1;36(9):1244-54. doi: 10.1016/j.clinthera.2014.06.030.

5.

Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.

Spence MM, Makarem AF, Reyes SL, Rosa LL, Nguyen C, Oyekan EA, Kiyohara AT.

J Manag Care Spec Pharm. 2014 Oct;20(10):1036-45.

6.

Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.

Morgado M, Rolo S, Castelo-Branco M.

Int J Clin Pharm. 2011 Feb;33(1):132-40. doi: 10.1007/s11096-010-9474-x.

7.

Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.

Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, Bosworth HB, Radcliff T, Davis R, Mun H, Weaver J, Barnett C, Barón A, Del Giacco EJ.

JAMA Intern Med. 2014 Feb 1;174(2):186-93. doi: 10.1001/jamainternmed.2013.12944.

PMID:
24247275
8.

Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.

Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC.

Ann Intern Med. 2007 May 15;146(10):714-25.

PMID:
17502632
9.

Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients.

Neto PR, Marusic S, de Lyra Júnior DP, Pilger D, Cruciol-Souza JM, Gaeti WP, Cuman RK.

J Pharm Pharm Sci. 2011;14(2):249-63.

10.

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Parag V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A.

BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318.

11.

A multimodal blood pressure control intervention in 3 healthcare systems.

Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, Lambert-Kerzner AC, Plomondon ME, Havranek EP.

Am J Manag Care. 2011 Apr;17(4):e96-103.

PMID:
21774100
12.
13.

A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project.

Keyserling TC, Ammerman AS, Davis CE, Mok MC, Garrett J, Simpson R Jr.

Arch Fam Med. 1997 Mar-Apr;6(2):135-45.

PMID:
9075448
14.

Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.

Kirwin JL, Cunningham RJ, Sequist TD.

J Manag Care Pharm. 2010 Mar;16(2):104-13.

15.

Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial.

Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, Bermann M, Kerr EA.

Circulation. 2012 Jun 12;125(23):2863-72. doi: 10.1161/CIRCULATIONAHA.111.089169.

16.

Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study.

Heisler M, Hofer TP, Klamerus ML, Schmittdiel J, Selby J, Hogan MM, Bosworth HB, Tremblay A, Kerr EA.

Trials. 2010 Oct 12;11:95. doi: 10.1186/1745-6215-11-95.

17.

A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans.

Ogedegbe GO, Boutin-Foster C, Wells MT, Allegrante JP, Isen AM, Jobe JB, Charlson ME.

Arch Intern Med. 2012 Feb 27;172(4):322-6. doi: 10.1001/archinternmed.2011.1307.

18.

Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial.

Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, Kerby TJ, Klotzle KJ, Maciosek MV, Michels RD, O'Connor PJ, Pritchard RA, Sekenski JL, Sperl-Hillen JM, Trower NK.

JAMA. 2013 Jul 3;310(1):46-56. doi: 10.1001/jama.2013.6549.

19.

Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.

Lau R, Stewart K, McNamara KP, Jackson SL, Hughes JD, Peterson GM, Bortoletto DA, McDowell J, Bailey MJ, Hsueh A, George J.

BMC Health Serv Res. 2010 Feb 5;10:34. doi: 10.1186/1472-6963-10-34.

20.

Impact of Appointment-Based Medication Synchronization on Existing Users of Chronic Medications.

Holdford D, Saxena K.

J Manag Care Spec Pharm. 2015 Aug;21(8):662-9.

Supplemental Content

Support Center